Technical Analysis for CING - Cingulate Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.89 | 0.15% | 0.00 |
CING closed up 0.15 percent on Wednesday, May 8, 2024, on 30 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 20 DMA Resistance | Bearish | 0.15% | |
| Wide Bands | Range Expansion | 0.15% | |
| Fell Below 20 DMA | Bearish | 1.99% | |
| Wide Bands | Range Expansion | 1.99% |
| Alert | Time |
|---|---|
| Possible NR7 | about 16 hours ago |
| Down 3% | about 18 hours ago |
| Down 2 % | about 18 hours ago |
| Gap Up Closed | about 20 hours ago |
| Gap Up Partially Closed | about 20 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/08/2024
Cingulate Inc. is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), Cingulate is identifying and evaluating additional therapeutic areas where PTR technology may be employed to develop future product candidates.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Neuroscience Pharmaceutical Products Attention Deficit Hyperactivity Disorder Amphetamine Methylphenidate Adhd Educational Psychology
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Neuroscience Pharmaceutical Products Attention Deficit Hyperactivity Disorder Amphetamine Methylphenidate Adhd Educational Psychology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 21.8 |
| 52 Week Low | 0.75 |
| Average Volume | 172,879 |
| 200-Day Moving Average | 6.25 |
| 50-Day Moving Average | 1.04 |
| 20-Day Moving Average | 0.90 |
| 10-Day Moving Average | 0.93 |
| Average True Range | 0.11 |
| RSI (14) | 42.86 |
| ADX | 11.58 |
| +DI | 20.60 |
| -DI | 21.24 |
| Chandelier Exit (Long, 3 ATRs) | 0.82 |
| Chandelier Exit (Short, 3 ATRs) | 1.09 |
| Upper Bollinger Bands | 1.05 |
| Lower Bollinger Band | 0.75 |
| Percent B (%b) | 0.46 |
| BandWidth | 32.93 |
| MACD Line | -0.05 |
| MACD Signal Line | -0.06 |
| MACD Histogram | 0.0177 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.99 | ||||
| Resistance 3 (R3) | 1.00 | 0.96 | 0.98 | ||
| Resistance 2 (R2) | 0.96 | 0.94 | 0.96 | 0.97 | |
| Resistance 1 (R1) | 0.93 | 0.92 | 0.91 | 0.92 | 0.96 |
| Pivot Point | 0.89 | 0.89 | 0.88 | 0.89 | 0.89 |
| Support 1 (S1) | 0.86 | 0.87 | 0.84 | 0.85 | 0.81 |
| Support 2 (S2) | 0.82 | 0.85 | 0.82 | 0.81 | |
| Support 3 (S3) | 0.79 | 0.82 | 0.80 | ||
| Support 4 (S4) | 0.78 |
